Kronos Bio Highlights Preclinical Data that Show p300 KAT Inhibitors Reduce Inflammation …

SAN MATEO, Calif. and CAMBRIDGE, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) — Kronos Bio, Inc. (Nasdaq: KRON), a company developing small molecule …

Do you trust this headline?

Based on recent headline ratings, 86% of this readership currently trusts the local media, which has an average score of 84% regionally and is currently trending positivepositive.

86%

Media Trust Score